VTGN analyst estimates
Vistagen Therapeutics (VTGN) analyst ratings, the average price target and its range, and every firm's latest call.
- 3 firms rate VTGN: 0 buy, 3 hold, 0 sell.
- The average price target is $0.95 from None analysts, from $0.90 to $1.00.
VTGN analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Dec 17, 2025 | Stifel Nicolaus | Vistagen downgraded to Hold at Stifel after PALISADE-3 study disappoints | $1.00 |
| Dec 17, 2025 | Jefferies | Jefferies Downgrades VistaGen Therapeutics (VTGN) to Hold | $0.90 |
| Nov 17, 2025 | Stifel Nicolaus | Stifel Reiterates Buy Rating on VistaGen Therapeutics (VTGN) | $12.00 |
| Jul 22, 2022 | Jefferies | VistaGen Therapeutics downgraded to Hold from Buy at Jefferies | $0.20 |